Clinical Trial: Study on the Estimation and Trends of Hepatocellular Carcinoma Classification, Incidence, Mortality, and Risk Factor Attributable Burden Globally and in China (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Estimation and Trends of Hepatocellular Carcinoma Classification, Incidence, Mortality, and Risk Factor Attributable Burden Globally and in China'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130527

Registration Time: 2026/08/20

Type: Observational study

Primary Sponsor: Guangxi Medical University Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338896

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Study on the Estimation and Trends of Hepatocellular Carcinoma Classification, Incidence, Mortality, and Risk Factor Attributable Burden Globally and in China (China)